| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |